These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7003388)

  • 1. Immunoadsorption for removal of A and B blood-group antibodies.
    Bensinger WI; Baker DA; Buckner CD; Clift RA; Thomas ED
    N Engl J Med; 1981 Jan; 304(3):160-2. PubMed ID: 7003388
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma exchange and immunoadsorption for removal of antibodies prior to ABO incompatible bone marrow transplant.
    Bensinger WI
    Artif Organs; 1981 Aug; 5(3):254-8. PubMed ID: 7030280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO-incompatible bone marrow transplantation: in vivo adsorption, an old forgotten method.
    Tichelli A; Gratwohl A; Wenger R; Osterwalder B; Nissen C; Burri HP; Speck B
    Transplant Proc; 1987 Dec; 19(6):4632-7. PubMed ID: 3321636
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohematologic problems arising from ABO incompatible bone marrow transplantation.
    Sniecinski IJ; Petz LD; Oien L; Blume KG
    Transplant Proc; 1987 Dec; 19(6):4609-11. PubMed ID: 3321631
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody to blood group glycosyltransferases in a patient transplanted with an ABO incompatible bone marrow.
    Kominato Y; Fujikura T; Takizawa H; Hayashi K; Mori T; Matsue K; Yasue S; Matsuda T
    Exp Clin Immunogenet; 1990; 7(2):85-90. PubMed ID: 2108709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of immunoadsorption and double filtration plasmapheresis for removal of anti-A or -B antibody in ABO-incompatible kidney transplantation. Japanese Biosynsorb Research Group.
    Agishi T; Takahashi K; Ota K; Yagisawa T
    Transplant Proc; 1992 Apr; 24(2):557-8. PubMed ID: 1566429
    [No Abstract]   [Full Text] [Related]  

  • 7. ABO incompatibility in liver transplantation: a single center experience.
    Steininger R; Mühlbacher F; Hamilton G; Zadrobilek E; Höcker P; Hajek A; Piza F
    Transplant Proc; 1987 Dec; 19(6):4586-8. PubMed ID: 3321624
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune adsorption of anti-A and anti-B antibodies.
    Bensinger WI; Buckner CD; Williams B; Clift RA
    Prog Clin Biol Res; 1982; 88():295-300. PubMed ID: 7048329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for different kinds of major ABO incompatibility in transplantation due to the interplay of qualitative and quantitative factors: application to the management of 62 bone marrow recipients.
    Reviron J; Schenmetzler C; Bussel A; Devergie A; Gluckman E
    Transplant Proc; 1987 Dec; 19(6):4623-8. PubMed ID: 3321634
    [No Abstract]   [Full Text] [Related]  

  • 10. Transplantation of blood group A2 kidneys into O or B recipients: the effect of pretransplant anti-A titers on graft survival.
    Welsh KI; van Dam M; Koffman CG; Bewick ME; Rudge CJ; Taube DH; Clark AG
    Transplant Proc; 1987 Dec; 19(6):4565-7. PubMed ID: 3321621
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma immunoadsorption combined with exchange for removal of isohemagglutinin in major ABO-incompatible bone marrow transplantation: a case report.
    Akao Y; Matsuzaki M; Naito K; Naoe T; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1258-62. PubMed ID: 3318267
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose.
    Rydberg L; Bengtsson A; Samuelsson O; Nilsson K; Breimer ME
    Transpl Int; 2005 Jan; 17(11):666-72. PubMed ID: 15551052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical aspects of antibody immunoadsorption prior to ABO-incompatible renal transplant.
    Raja R; McAlack R; Mendez M; Bannett A
    Transplant Proc; 1987 Dec; 19(6):4525-7. PubMed ID: 3321613
    [No Abstract]   [Full Text] [Related]  

  • 14. Obstacle to red cell engraftment due to major ABO incompatibility in allogeneic bone marrow transplants (BMT): quantitative and kinetic aspects in 58 BMTs.
    Reviron J; Schenmetzler C; Bussel A; Frappaz D; Devergie A; Gluckman E
    Transplant Proc; 1987 Dec; 19(6):4618-22. PubMed ID: 3321633
    [No Abstract]   [Full Text] [Related]  

  • 15. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation.
    Ohta S; Yokoyama H; Ise T; Takasawa K; Wada T; Nakao S; Matsuda T; Kobayashi K
    Intern Med; 1997 Jul; 36(7):487-91. PubMed ID: 9240498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption and renal transplant in two patients with a major ABO incompatibility.
    Bannett AD; Bensinger WI; Raja R; Baquero A; McAlack RF
    Transplantation; 1987 Jun; 43(6):909-11. PubMed ID: 3296358
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
    Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
    Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies.
    Kumlien G; Ullström L; Losvall A; Persson LG; Tydén G
    Transfusion; 2006 Sep; 46(9):1568-75. PubMed ID: 16965585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO-incompatible kidney transplantation: first cases in Turkey.
    Tuncer M; Yücetin L; Tekin S; Demirbas A
    Transplant Proc; 2012; 44(6):1703-5. PubMed ID: 22841248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present techniques for antibody removal.
    Tydén G; Kumlien G; Efvergren M
    Transplantation; 2007 Dec; 84(12 Suppl):S27-9. PubMed ID: 18162984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.